MedPath

Aummune Ltd.

Aummune Ltd. logo
🇮🇱Israel
Ownership
Private
Established
2017-05-01
Employees
1
Market Cap
-
Website
http://www.aummune.com

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Study of AM003 in Patients With Locally Advanced and Metastatic Solid Tumors

Phase 1
Completed
Conditions
Solid Tumor
Interventions
First Posted Date
2024-02-14
Last Posted Date
2025-01-28
Lead Sponsor
Aummune Ltd.
Target Recruit Count
12
Registration Number
NCT06258330
Locations
🇮🇱

Rambam Health Care Campus, Haifa, Israel

🇮🇱

Hadassah Medical Center, Jerusalem, Israel

🇮🇱

Rabin Medical Center, Petach Tikva, Israel

and more 2 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.